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Abstract
The aim of the study was to determine whether diaphragm-protective mechanical ventilation can prevent diaphragm atrophy 
in children with respiratory failure.
Materials and methods. We complete the prospective single-center cohort study. Data analysis included 82 patients 1 month – 
18 years old, divided into I group (lung-protective MV) and II group (diaphragm-protective in addition to lung-protective MV).
Patients were divided into age subgroups. Stages of the study: 1st day (d1), 3rd (d3), 5th (d5), 7th (d7), 9th (d9), 28th (d28). We stu-
died changes in diaphragm thickness at the end of exhalation and compared them with these indicators at patient’s admission to the 
study (baseline). Primary endpoint was length of stay in ICU, secondary endpoints were complications (prolonged MV). Results are 
described as arithmetic mean (X) and standard deviation (σ) with level of significance p.
Results. There were significant differences in length of stay in ICU among patients of the 1st and 5th age subgroups: in 1st age 
subgroup this data was in 1.3 times lower in II group, compared with I group (p < 0,05); in 5th age subgroup the situation was the 
opposite – length of stay in ICU was in 1.4 times higher in II group, compared with I group (p < 0.05). There were no patients who 
required lifelong mechanical ventilation in any of the groups.
Changes in the thickness of the diaphragm, which indicate its atrophy, were the most significant among patients of the first, se-
cond, third and fourth age subgroups and the severity of atrophy was higher among patients of group I, compared with patients of group II.
Conclusions. Diaphragm-protective mechanical ventilation significantly prevents diaphragm atrophy in children with respiratory 
failure in 2nd, 4th, and 5th age subgroups. Providing goal-directed diaphragm-protective MV might reduce the length of stay in ICU among 
patients of 1st and 5th age subgroups. There were no observed complications like lifelong mechanical ventilation in both patient’s group.




Atrophy and weakness of the peripheral and respiratory muscles is well known problem in 
intensive care unit (ICU) [1]. Severe weakness of the diaphragm frequently occurs due to prolonged 
mechanical ventilation (MV) and lead to outcomes worsening and increased mortality rate [2, 3]. 
We know that diaphragmatic function is a major determinant of the ability to be successfully 
weaned from MV for patients [4]. However, despite thorough knowledge in molecular mechanisms 
of diaphragm injury due to MV, it is hard to find out the best clinical strategy how to prevent this 
complication. On the other hand, enough level of spontaneous breathing pattern function together 
with work of respiratory muscles might be a key how to solve this clinical problem. It seems to be 
possible to provide carefull selection of MV parameters with taking into account diaphragm func-
tion for each patient.
The aim of the study was to determine whether diaphragm-protective mechanical ventila-
tion can prevent diaphragm atrophy in children with respiratory failure.
2. Materials and methods
In January 2018 – April 2020 it was completed the prospective single-center cohort study 
at the Department of Anesthesiology and Intensive Care, Danylo Halytsky Lviv National Medi-
cal University; Department of Anesthesiology and Intensive Care, Lviv Regional Children Hospi-
tal «OCHMATDYT». We included patients with acute respiratory failure who was mechanically 
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ventilated. Exclusion criteria for the study were: the refusal of the patient’s legal representatives 
to participate in the study at any of its stages, the patient’s agonizing state upon admission, and 
a second trial of MV with its onset less than 48 h after prior weaning.
The study was conducted in accordance with the requirements of good clinical practice, 
the Council of Europe Convention on Human Rights and Biomedicine, the Helsinki Declaration of 
the World Medical Association. The study was approved by the Bioethics Commission of Danylo 
Halytsky Lviv National Medical University, protocol No. 1, January 30, 2018. All patients’ relatives 
or their legal representatives signed informed consent to participate in the study.
The study included 89 patients aged 1 month – 18 years. All patients were randomly divided 
into 2 groups (using random.org). Group I included patients who received lung-protective venti-
lation strategy, group II – patients who received diaphragm-protective in addition to lung-protec-
tive ventilation strategy. 82 patients were included in the data analysis. We studied indicators of 
diaphragm function (amplitude of diaphragm movement and it was considered that decreasing of 
this indicator less than 8 mm was a marker of under-assistance during MV and increasing of this 
indicator over 15 mm was a marker of over-assistance during MV; thickening fraction and it was 
considered that decreasing of this indicator less than 15 % was a marker of diaphragm weakness; 
increasing it up to more than 35 % was a marker of high respiratory function and a potentially da-
maging factor for diaphragm), parameters of acid-base balance and mechanical ventilation. 
We studied the relative changes in right hemidiaphragm thickness and compared them with 
the baseline data.
We divided patients into age subgroups: 1 subgroup – children 1 month – 1 year; 2nd sub-
group – children 1–3 years; 3 subgroup – children 3–6 years; 4 subgroup – children 6–13 years; 
5 subgroup – children 13–18 years.
Stages of the study: 1st day (d1), 3rd day (d3), 5th day (d5), 7th day (d7), 9th day (d9), 28th day (d28).
Primary endpoint was length of stay in ICU, secondary endpoints were complications (pro-
longed MV).
Statistical analysis of the study results was performed using MS Excel 2017 with the calcu-
lation of arithmetic mean (X) and standard deviation (σ). Parametric criteria (Student’s t-test) were 
used and the difference was considered statistically significant at p < 0.05.
3. Results
There were significant differences in length of stay in ICU among patients of the 1st and 
5th age subgroups (Table 1): in 1st age subgroup this data was in 1.3 times lower in II group, com-
pared with I group (p < 0,05); in 5th age subgroup the situation was opposite – length of stay in 
ICU was in 1.4 times higher in II group, compared with I group (p < 0.05).
Table 1
Primary endpoint, Х ± σ
Criteria Patient’s age subgroup І group ІІ group P
Length of stay in 
ICU, days
1st 16.3 ± 1.2 12.1 ± 0.3 0.03
2nd 9.8 ± 0.7 9.1 ± 0.3 0.22
3rd 13.2 ± 1.1 14.5 ± 1.2 0.51
4th 14.6 ± 1,3 11.4 ± 1.1 0.08
5th 8.5 ± 0.6 12.3 ± 1.6 0.04
There were no patients who required lifelong mechanical ventilation in any of the groups.
We analyzed the dynamics of changes of right hemidiaphragm thickness during the 
study (Tablе 2) and found that in 1st age subgroup in I group there was a tendency to decrease this 
indicator at stage d3 from 3.3 ± 0.3 mm to 2.7 ± 0.2 mm, which mean 22.2 % decrease from base-
line, and up to 2.0 ± 0.1 mm on d9, which was 65 % decrease from baseline. Whereas in II group, the 
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maximum decrease of diaphragm thickness was at the stage d3 from 3.1 ± 0.2 mm to 2.9 ± 0.3 mm 
what was 6.9 % decrease from baseline. All differences between the I and II groups in 1st age sub-
group were nonsignificant.
Table 2
Changes of right hemidiaphragm thickness along the study, X ± σ




Right hemidiaphragm  
thickness at the end  
of exhalation, mm 
1st d1 3.3 ± 0.3 3.1 ± 0.2 0.69
d3 2.7 ± 0.2 2.9 ± 0.3 0.16
d5 2.5 ± 0.1 3.1 ± 0.2 0.12
d7 2.4 ± 0.1 3.0 ± 0.1 0.08
d9 2.0 ± 0.1 3.2 ± 0.2 0.16
2nd d1 3.5 ± 0.3 3.2 ± 0.2 0.12
d3 2.8 ± 0.1 3.5 ± 0.2 0.04
d5 2.7 ± 0.2 3.3 ± 0.1 0.02
d7 2.9 ± 0.1 3.1 ± 0.2 0.25
d9 3.1 ± 0.1 3.3 ± 0.2 0.18
3rd d1 4.1 ± 0.1 4.0 ± 0.2 0.89
d3 3.2 ± 0.2 3.8 ± 0.2 0.21
d5 3.4 ± 0.1 3.9 ± 0.2 0.09
d7 3.3 ± 0.2 3.7 ± 0.1 0.1
d9 3.1 ± 0.2 3.9 ± 0.1 0.06
4th d1 4.9 ± 0.3 4.7 ± 0.2 0.39
d3 3.7 ± 0.1 4.8 ± 0.1 0.08
d5 3.8 ± 0.2 4.5 ± 0.3 0.02
d7 3.6 ± 0.1 4.6 ± 0.1 0.05
d9 3.9 ± 0.2 4.8 ± 0.1 0.001
5th d1 4.4 ± 0.3 4.6 ± 0.2 0.45
d3 4.1 ± 0.2 4.7 ± 0.3 0.02
d5 4.0 ± 0.1 4.2 ± 0.1 0.43
d7 4.2 ± 0.1 4.5 ± 0.3 0.18
d9 4.1 ± 0.2 5.1 ± 0.2 0.03
Changes in diaphragm thickness in 2nd age subgroup had the highest values in group I on 
stage d5 when the thickness was 2.7 ± 0.2 mm compared with 3.5 ± 0.3 mm on stage d1, which was 
29.6 % decrease from baseline values, and in group II the maximum decrease was achieved on 
stage d3 and was 9.9 % from baseline. Diaphragm thickness values were significantly higher on 
study stages d3 and d5 in group II compared with group I.
In 3rd age subgroup the largest reduction in diaphragm thickness in I group was achieved 
on d9, when it was 32.3 % from baseline, whereas in II group the maximum reduction was 8.1 % on 
d7 stage. All differences between I and II groups in 1st age subgroup were nonsignificant.
Among patients of 4th age subgroup the decrease in diaphragm thickness was the largest 
in I group on d7 and was up to 36.1 % from baseline, while in II group – 11.9 % on stage d5. There 
were significant differences in diaphragm thickness in patients of I and II groups on stages d5 
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and d9 (Table 2): thickness was 3.8 ± 0.2 mm on d5 in I group vs 4.5 ± 0.3 mm in II group (p < 0.05); 
and – 3.9 ± 0.2 mm on d9 in I group vs 4.8 ± 0.1 mm in II group (p < 0.05).
In 5th age subgroup the thickness of the diaphragm during the study decreased less sig-
nificantly than in other age subgroups. The maximum decrease was registered in I and II groups 
on stage d5 and were 10 % from baseline in I group and 9.5 % from baseline in II group and the 
differences between I and II groups were significant. The thickness of the right hemidiaphragm in 
I group was 4.1 ± 0.2 mm vs 4.7 ± 0.3 mm in II group (p < 0.05).
4. Discussion
Data on the prevalence of diaphragmatic atrophy in children with respiratory failure re-
main poorly understood, despite a significant number of publications on this clinical problem in 
adults [4, 5]. It is known, that weaning from MV depends on achievement a lot of parameters and 
the duration of MV is included in this list [6, 7]. As long we provide MV, as higher is the incidence 
weakness of diaphragm and its atrophy [8, 9]. Therefore, it is normal function of diaphragm during 
MV might improve outcomes in such patients.
Both the absence of diaphragm activity and excessive inspiratory effort can result in dia-
phragm muscle weakness, and recent evidence demonstrates that a moderate level of diaphragm 
activity during mechanical ventilation improves ICU outcome [10] and we in our previous study 
established that the prevalence and variety of manifestations of diaphragm dysfunction depend on 
the strategy of MV and low incidence of it was associated with lower duration of MV [11]. How-
ever, the other studies [12] found, that increasing age of child and presence of traumatic brain 
injury were associated with greater skeletal muscle loss in children on invasive MV. On the other 
hand, a great number of patients already are admitted to ICU with muscle weakness [13], and 
there are no data about this in paediatric population. Secondly, it is clear in adults that respiratory 
weakness is independently associated with long-term mortality [14], but we have no paediatric 
data about this. And low maximal inspiratory pressure is frequent in patients on MV mechanical 
ventilation due to muscles atrophy and is an independent risk factor for long-term mortality in ICU 
patients requiring mechanical ventilation [1, 14].
In addition to maintaining enough oxygenation level and elimination of CO2 we have to 
prevent injury to the lung which is mediated by excessive mechanical stress and strain, on the 
other hand the diaphragm atrophy might develops as a consequence of low respiratory effort and 
injury in case of excessive effort [15]. The lung and diaphragm-protective mechanical ventilation 
approach aims to protect both organs simultaneously whenever possible.
One more option is diaphragm pacing in ICU patients. However, there is yet no clinical 
evidence of benefit from this method [16]. Direct stimulation of the phrenic nerves by surgical-
ly implanted electrodes has been employed to restore spontaneous ventilation in patients with 
high-level spinal cord injury and central hypoventilation syndrome. Recently, Reynolds et al. pre-
sented a first-in-human series of temporary transvenous phrenic nerve pacing in surgical patients 
and showed that this technology delivered safe and effective diaphragm contractions [17]. This 
strategy is currently being studied as potential intervention for improving diaphragm strength in 
difficult-to-wean patients.
One more approach to lung and respiratory muscle-protective ventilation is partial neuro-
muscular blockade [18, 19]. It is well known that complete neuromuscular blockade may increase 
the risk for diaphragm disuse atrophy and increases sedation requirements, whereas low-dose neu-
romuscular blockers («partial neuromuscular blockade») is an interesting compromise between 
total paralysis and strenuous breathing efforts [15]. 
In our study we found age-specific features of presence and severity of diaphragm atrophy 
during MV in children: in 1st, 2nd, 3rd and 4th age subgroup there were the most severe diaphragm 
atrophy in comparison with 5th age subgroup.
Limitations of the study. There were several limitations in the study. First, neither results 
assessor nor medical staff, who take care for patients, could not be blinded to group allocation be-
cause of the nature of the study. Second, the number of patients, who were included in the study, 
have to be enlarged in order to achieve significant differences in data which we studied. 
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Prospects for further research. Further studies are required to evaluate whether dia-
phragm atrophy might has impact on 28-days mortality rate in different age subgroups of children. 
5. Conclusions
1) Diaphragm-protective mechanical ventilation significantly prevents diaphragm atrophy 
in children with respiratory failure in 2nd, 4th, and 5th age subgroups. In 2nd age subgroup on d3 
it was reached 29.6 % (I group) vs 9.9 % (ІІ group) decreasing diaphragm thickness from base-
line (p < 0.05); in 4th age subgroup on d5 – 28.9 % from baseline (I group) vs 4.4 % (ІІ group), 
p < 0.05; in 5th age subgroup on d9 – 7.3 % decreasing from baseline (I group) vs 10.9 % increasing 
from baseline (I group), p < 0.05.
2) Providing goal-directed diaphragm-protective MV might reduce the length of stay in 
ICU among patients of 1st and 5th age subgroups.
3) There were no observed complications like lifelong mechanical ventilation in both pa-
tient’s group.
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